Medicine
Osteoporosis Screening and Fracture Risk Assessment in Postmenopausal Women
Quick fact
The FRAX® tool can estimate a woman's 10-year probability of hip or major osteoporotic fracture using clinical risk factors alone, even before a bone density scan, so a T-score is not always required to begin the assessment.
Why this is interesting
A simple bone density number might seem clear-cut, but two women with the same T-score can have vastly different fracture odds. What tips the scales?
Read the full explanation
Understanding Osteoporosis Screening and Fracture Risk Assessment in Postmenopausal Women
Think of bone density as a measure of bone 'strength reserve.' After menopause, declining estrogen accelerates bone loss, making bones more porous and fragile. Screening for osteoporosis typically starts with a DXA scan, which measures bone density at the hip and spine. The result is reported as a T-score, which compares your bone density to that of a healthy 30-year-old adult. A T-score of -1.0 or above is normal, between -1.0 and -2.5 indicates osteopenia (low bone mass), and -2.5 or lower defines osteoporosis. But a T-score alone is only half the story: a 60-year-old woman with a T-score of -2.0 but no other risk factors has a different fracture risk than a 75-year-old smoker with a family history of hip fracture. That is why clinical guidelines recommend a comprehensive risk assessment that combines bone density with age, sex, weight, prior fractures, smoking, alcohol use, and other factors—often using the FRAX tool, which calculates the 10-year probability of a major osteoporotic fracture.
A deeper explanation
Fracture risk is not a single number but a probability influenced by multiple interacting factors. The primary mechanical determinant is bone strength, which is a product of bone density and bone quality (microarchitecture, turnover, and damage accumulation). The DXA T-score captures density but not quality. The FRAX tool, developed by the World Health Organization, models the two main determinants of fracture risk: the current bone mass and the rate of bone loss. FRAX integrates 12 clinical risk factors (age, BMI, prior fracture, parental hip fracture, smoking, glucocorticoid use, rheumatoid arthritis, secondary osteoporosis, alcohol intake, and others) with the femoral neck BMD (if available) to generate a 10-year absolute risk of hip fracture and major osteoporotic fracture. The resulting probability is compared against country-specific intervention thresholds to decide whether to recommend pharmacologic therapy. This mechanism matters because it shifts the goal from labeling a disease to predicting a harmful event (fracture), thereby targeting treatment to those most likely to benefit. Understanding this process reveals why screening isn't just about detecting low bone density; it's about stratifying risk and preventing disability.